Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 8/20 | 0.56 |
| ▸ | GSK3B | P49841 | 8/20 | 0.56 |
| ▸ | MEN1 | O00255 | 6/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | GAA | P10253 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2788487 | 0.89 | MEN1 (0.59) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL3062340 | 0.87 | GSK3A (0.62) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL186221 | 0.87 | MEN1 (0.62) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL28886326 | 0.85 | MEN1 (0.65) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL19220386 | 0.85 | MEN1 (0.65) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL16274020 | 0.85 | MEN1 (0.65) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL26286 | 0.85 | MEN1 (0.65) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL20176213 | 0.85 | MEN1 (0.65) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL14850663 | 0.85 | MEN1 (0.65) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL153669 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-59125725-A | — | — | None | — | — | JP | disclosed |
| WO-2023064368-A1 | NOVEL RHODANINE DERIVATIVES AND USES THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| EP-2943584-B1 | MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT | CANON KK (JP) | 2019-08-14 | — | — | EP | disclosed |
| CN-108976222-A | Biaryl Oxazolidinone compound containing heterocycle and preparation method thereof | 沈阳药科大学 | 2018-12-11 | — | — | CN | disclosed |
| US-10041937-B2 | Macrophage identification agent, and identification method, sorting method, evaluation method, screening method and kit using the macrophage identifier agent | CANON KABUSHIKI KAISHA (JP) | 2018-08-07 | — | — | US | disclosed |
| US-10041937-B2 | Macrophage identification agent, and identification method, sorting method, evaluation method, screening method and kit using the macrophage identifier agent | CANON KABUSHIKI KAISHA (JP) | 2018-08-07 | — | — | US | disclosed |
| US-20160018389-A1 | MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT | CANON KABUSHIKI KAISHA (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20160018389-A1 | MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT | CANON KABUSHIKI KAISHA (JP) | 2016-01-21 | — | — | US | disclosed |
| WO-2014192972-A1 | MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT | CANON KABUSHIKI KAISHA (JP) | 2014-12-04 | — | — | WO | disclosed |
| US-20120219613-A1 | Novel Antiviral Agents for Enveloped Viruses | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-08-30 | — | — | US | disclosed |
| WO-2010044924-A1 | NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-04-22 | — | — | WO | disclosed |
| JP-S59125725-A | PHOTOPOLYMERIZABLE RESIN COMPOSITION | MITSUBISHI RAYON CO LTD | 1984-07-20 | — | — | JP | disclosed |
| US-4375508-A | ACETHYLENIC HYDROCARBON CHAIN | EASTMAN KODAK COMPANY (US) | 1983-03-01 | — | — | US | disclosed |
| US-4283488-A | SILVER HALIDE EMULSIONS | EASTMAN KODAK COMPANY (US) | 1981-08-11 | — | — | US | disclosed |
| US-4108667-A | Photographic compositions and elements containing benzo[a]quinolizinium methine dyes | EASTMAN KODAK COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-4003750-A | METHINE DYES | EASTMAN KODAK COMPANY (US) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10041937-B2 | Macrophage identification agent, and identification method, sorting method, evaluation method, screening method and kit using the macrophage identifier agent | CD68, MSR1, MYADM | GSK3A 4486/4885GSK3B 4706/4885MEN1 1787/4885 |
| US-20120219613-A1 | Novel Antiviral Agents for Enveloped Viruses | MAVS, LAMP1, HAVCR2 | GSK3A 4523/4885GSK3B 4599/4885MEN1 4512/4885 |
| US-20160018389-A1 | MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT | CD68, MSR1, MYADM | GSK3A 4486/4885GSK3B 4706/4885MEN1 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.